Last fall, a group of experts advising the U.S. Food and Drug Administration debated for two days on how to regulate generative artificial intelligence tools in medicine. One report presented at the meeting showed that a generative AI tool supposedly used by 40% of the radiology practices in the U.S. produced clinically significant errors in one of every 21 reports.\u00a0<\/p>\n
Those errors, \u201cI\u2019ll be honest, gave me palpitations,\u201d said committee chair Ami Bhatt, chief innovation officer at the American College of Cardiology, at the meeting. \u201cAnd I don\u2019t just say that because I\u2019m a cardiologist.\u201d The committee considered many complicating factors in generative AI regulation, but the FDA has not yet issued any guidelines on how it plans to police the technology.<\/p>\n
In Europe, things are moving faster. In April, the U.K.\u2019s National Health Service said it would regulate highly popular ambient AI scribes as Class 1 medical devices<\/a>. Earlier, in March, the first generative AI tool for providing medical information, \u201cProf. Valmed,\u201d was certified in Europe<\/a> as a medium-to-high-risk medical device. While the U.S. FDA has shied away from judging whether all medical generative AI tools count as medical devices and need approval, the decisions from the U.K. and Europe raise the question yet again for American regulators.\u00a0\u00a0<\/p>\n STAT+ Exclusive Story<\/p>\n Already have an account? Log in<\/a><\/p>\n \t\t\t \t\t\t\t\t \t\t\t\tThis article is exclusive to STAT+ subscribers Already have an account? Log in<\/a><\/p>\n \t\t\t\t\t\tIndividual plans<\/p>\n \t\t\t\t\t\tGroup plans<\/p>\n![\"STAT+\"\/](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/06\/stat-plus-breaker-bg.png\")
<\/p>\n
\n\t\t\t\t\t\t![\"STAT+\"\/](\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\"){kind=logo}
\n\t\t\t\t\t<\/a><\/p>\n
\n\t\t\t\tUnlock this article \u2014 and get additional analysis of the technologies disrupting health care \u2014 by subscribing to STAT+.<\/p>\n